GENE ONLINE|News &
Opinion
Blog

2026-02-03|

Nova Minerals Plans US Redomicile and Full Acquisition of Estelle Gold Project in Alaska

by GOAI
Share To

Nova Minerals has announced plans to redomicile its corporate headquarters to the United States and aims to secure full ownership of the Estelle Gold Project. The company currently operates under Australian jurisdiction and holds a majority stake in the Estelle Project, located in Alaska. This move is intended to align Nova Minerals’ operations more closely with its primary asset’s location while consolidating ownership of the project.

The Estelle Gold Project is situated in Alaska’s prolific Tintina Gold Belt, an area known for significant gold deposits. Nova Minerals presently owns 85% of the project and seeks to acquire the remaining 15% interest held by joint venture partner, AKCM (Alaska Centennial Mining). The company states that this strategic decision will streamline management processes and enhance operational efficiency. No timeline or further details regarding the redomiciling process or acquisition negotiations have been disclosed at this time.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: February 4, 2026

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
NorthWestern Energy Reports $1.4 Billion Revenue and $150 Million Net Income for 2025
2026-02-11
Nissay Asset Management Corporation Becomes First in Japan to Implement Broadridge’s MBS Trade Assignment Portal
2026-02-11
Ballard Power Systems Schedules February 12, 2026 Conference Call to Discuss 2025 Financial Results
2026-02-11
Zeus North America Mining Corp. Adjusts Private Placement Unit Price to $0.05
2026-02-11
February 2026 Review Questions Shareholder Deal Fairness at MCFT, SLAB, and MPX
2026-02-11
Questions Arise Over Shareholder Value in Financial Decisions by Nathan’s Famous, SkyWater Technology, and Gold Resource Corporation
2026-02-11
Pivekimab Sunirine Shows Promise as First-Line Treatment in BPDCN Clinical Trial
2026-02-11
EVENT
2026-02-09
World Health Expo Dubai
Dubai Exhibition Centre, Dubai
2026-02-17
BIO Asia 2026 (Life Science Partnerships)
Hyderabad, India
2026-02-24
Rare Disease Week on Capitol Hill (Policy and Advocacy)
Capitol Hill, Washington, D.C.
2026-03-09
HIMSS26 (Digital Health & Hospital IT)
Las Vegas, Nevada
2026-03-23
DCAT Week
New York, USA
Scroll to Top